Lasa Supergenerics Limited — Others, 30-01-2025: Shareholders meeting

Lasa Supergenerics Limited has announced a board meeting on February 22, 2025, to hold an Extraordinary General Meeting (EGM) via video conferencing. A key agenda item includes the issuance of 2,500,000 warrants, convertible into equity shares at a price of ₹28 each, to a promoter, with a total anticipated fundraising of ₹7 crores. This move aims to bolster the company's working capital and debt repayment. The issuance may enhance investor confidence by demonstrating a proactive approach to financial management, though attention is warranted regarding dilution of existing equity.